An understanding of interactions within the tumor microenvironment (TME) of classic
Hodgkin lymphoma (cHL) has helped pave the way to novel immunotherapies that have …

Patients with Hodgkin's disease, at presentation or in remission, exhibit a persistent defect in
cellular immunity. Natural killer cell mediated cytotoxicity is depressed in untreated patients …

These studies were designed to examine the immunomodulatory and immunotherapeutic
properties of recombinant murine interferon gamma (rM IFN-γ) and recombinant human …

Objective—To evaluate the antitumor and toxic effects of treatment with doxorubicin
combined with piroxicam or doxorubicin alone for multicentric lymphoma in dogs. Design …

Biological response modifiers (BRMs) are those agents or approaches that modify the
relationship between the tumor and host by modifying the host's biological response to the …

Augmentation of natural killer (NK) cell activity has been observed after the single
administration of a wide variety of biological response modifiers (BRM); however, multiple …

We have examined the recovery of natural killer (NK) cell function in seven recipients of
MHC matched T cell depleted bone marrow allografts. NK cell activity against the …

It has become increasingly evident that natural killer (NK) cells may play an important role in
defense against neoplasias and against exogenous intruders, such as viruses, bacteria, and …

Natural killer (NK) activity was investigated in 61 patients with Stage III and IV Hodgkin's
disease during the course of disease and in 30 healthy age‐and sex‐matched healthy …

This article focuses on natural killer (NK) cells in relation to disease and treatment. NK cells
are mainly functionally identified by their ability to lyse a variety of target cells. NK cell activity …